NDC properties for "Epogen" (RxCUI 205921)
About this data
The tables show NDC propoerties for Epogen with the RxCUI 205921
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Epogen (RxCUI 205921)
| BLA | BLA103234 |
|---|---|
| MMSL_CODE | BD30446 |
| RxCUI | 205921 |
| SPL_SET_ID | 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 |
| Prescribable Synonym | EPOGEN 3000 UNT in 1 ML Injection |
| RXNAV_STR | 1 ML Epogen 3000 UNT/ML Injection |
| RxNorm Name | 1 ML epoetin alfa 3000 UNT/ML Injection [Epogen] |
| RxNorm Synonym | 1 ML EPO 3000 UNT/ML Injection [Epogen] |
| RxNorm Synonym | 1 ML Epogen 3000 UNT/ML Injection |
| RxNorm Synonym | 1 ML ERYTHROPOIETIN 3000 UNT/ML Injection [Epogen] |
| RxNorm Synonym | Epogen 3000 UNT per 1 ML Injection |
| Related queries | Interactions (for RxCUI 205921) |
NDC Properties
NDC Item 55513026701
| NDC 9 | 55513-267 |
|---|---|
| NDC 10 | 55513-267-01 |
| NDC Item | 55513026701 |
| Packaging | 1 mL in 1 VIAL |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1990-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-267 |
NDC Item 55513026710
| NDC 9 | 55513-267 |
|---|---|
| NDC 10 | 55513-267-10 |
| NDC Item | 55513026710 |
| Packaging | 10 VIAL in 1 PACKAGE (55513-267-10) / 1 mL in 1 VIAL (55513-267-01) |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1990-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-267 |
NDC Item 55513026701
| NDC 9 | 55513-267 |
|---|---|
| NDC 10 | 55513-267-01 |
| NDC Item | 55513026701 |
| Packaging | 1 mL in 1 VIAL |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1990-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-267 |
NDC Item 55513026710
| NDC 9 | 55513-267 |
|---|---|
| NDC 10 | 55513-267-10 |
| NDC Item | 55513026710 |
| Packaging | 10 VIAL in 1 PACKAGE (55513-267-10) / 1 mL in 1 VIAL (55513-267-01) |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1990-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-267 |